Literature DB >> 17433933

Antiepileptic drug formulation and treatment in the elderly: biopharmaceutical considerations.

Barry E Gidal1.   

Abstract

The pharmacokinetics of antiepileptic drugs (AEDs) determine their effectiveness in the treatment of patients with epilepsy. Given the likelihood of comorbid medical conditions that require polytherapy, as well as the normal physiological changes associated with aging, an understanding of AED pharmacokinetics and pharmacodynamics in the elderly patient is critical. There is a relative sparsity of data regarding changes in the oral absorption patterns of AEDs that may accompany aging. Therefore, the objective of this chapter is to discuss fundamental principles related to oral drug absorption, and to discuss their potential impact on AED treatment in the older patient. Although most drugs are absorbed via the diffusion process, active transport also plays a role in absorption. While the gastrointestinal tract shows remarkable resilience during aging, physiological changes that influence oral and esophageal function, gastric pH, gastric emptying rates, and intestinal transit times do occur. Oral administration of AEDs may be affected by changes associated with aging, including altered oral protective reflexes, xerostomia, thickening of the esophageal smooth muscle layer, reduced contraction velocity and duration, altered esophageal emptying rates, and enteric plexus neuron reduction. Gastric acid secretion is similar between older and younger patients, but older patients require more time to return to baseline gastric pH values and have prolonged gastric emptying rates compared to younger patients. Elderly patients may similarly have reduced numbers of myenteric neurons, decreased postprandial contractions, reduced frequency of migrating motor complex, and diminished rectal compliance as well as reduced sphincter tones. All of these effects observed in the aging patient, in turn, produce numerous opportunities for changes in AED absorption, particularly for those agents demonstrating poor water solubility or variable absorption patterns.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17433933     DOI: 10.1016/S0074-7742(06)81020-2

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  4 in total

1.  The Controversy over Generic Antiepileptic Drugs.

Authors:  Susan J Shaw; Adam L Hartman
Journal:  J Pediatr Pharmacol Ther       Date:  2010-04

2.  Generic antiepileptic drugs.

Authors:  Susan J Shaw; Gregory L Krauss
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

Review 3.  Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age: an update.

Authors:  Domenico Italiano; Emilio Perucca
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

Review 4.  Managing Status Epilepticus in the Older Adult.

Authors:  Stephane Legriel; Gretchen M Brophy
Journal:  J Clin Med       Date:  2016-05-11       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.